Detail
| LncRNA Name | LSINCT5 |
| Synonyms | NA |
| Region | GRCh38_5:2712591-2715237 Sequence |
| Ensembl | NA |
| RefSeq | NR_145480 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | non small cell lung cancer |
| ICD-0-3 | C34 M8046/3 |
| Methods | qPCR, RIP, Microarray, Western blot, etc. |
| Sample | All the lung cancer cell lines (WI-38, A549, H1299, 95D, 95C, H838) |
| Expression Pattern | up-regulated |
| Function Description | In conclusion, our current work has revealed that lncRNA LSINCT5 serves as a novel oncogenic factor which is critically involved in NSCLC progression. LSINCT5 can enhance malignant phenotypes of lung cancer both in vitro and in vivo. LSINCT5 contributes to NSCLC tumorigenesis partially by physical interaction with and stabilizing HMGA2. Kaplan-Meier survival curves for patients with NSCLC. P < 0.01 by log-rank test. |
| Pubmed ID | 29883241 |
| Year | 2018 |
| Title | The long non-coding RNA LSINCT5 promotes malignancy in non-small cell lung cancerby stabilizing HMGA2. |
| External Links |
| Links for LSINCT5 | GenBank HGNC lncrnadb Noncode |
| Links for non small cell lung cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.